How much cash does Eton Pharmaceuticals, Inc. generate?

Eton Pharmaceuticals, Inc. (ETON) generated $29.5M in operating cash flow over the trailing twelve months.

What is Eton Pharmaceuticals, Inc.'s free cash flow?

After $408.0K of capital expenditures, Eton Pharmaceuticals, Inc.'s free cash flow was $29.1M over the trailing twelve months, up 1588.2% year over year.

Where does Eton Pharmaceuticals, Inc.'s cash flow data come from?

Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Eton Pharmaceuticals, Inc. ETON Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net income	——	-$3.82M-308%	-$936K—	——
Depreciation and amortization	$4.04M+253%	$1.15M+27.2%	$901K-49.2%	$1.77M+284%
Stock-based compensation	$5.51M+74.2%	$3.17M+0.9%	$3.14M-25.6%	$4.22M+24.8%
Change in accounts receivable	——	$3.12M+89.8%	$1.64M—	——
Change in inventories	——	——	——	$7K—
Change in accounts payable	——	$2.45M+4,519%	$53K—	——
Change in accrued liabilities	$1.01M—	——	——	$1.51M—
Change in other assets	——	$3.35M—	——	——
Other working capital changes	——	——	——	——
Non-cash operating lease expense	$44K-64.2%	$123K+83.6%	$67K+8.1%	$62K—
Debt issuance costs and discount amortization	$706K-36.7%	$1.12M+854%	$117K-37.4%	$187K+26.4%
Net cash from operating activities	——	——	$6.82M—	——
Capital expenditures	$333K—	——	$0-100%	$38K—
Acquisitions, net of cash acquired	$0-100%	$30M—	$0—	$0—
Purchases of intangible assets	$0—	——	$775K—	——
Net cash from investing activities	-$333K—	——	-$775K+72.2%	-$2.79M—
Proceeds from issuance of common stock	——	$1.19M—	——	——
Net cash from financing activities	——	$32.59M+3,506%	-$957K—	——
Net increase (decrease) in cash	——	——	——	$1.9M+128%
Interest paid	$3.33M+400%	$665K-21.0%	$842K+15.3%	$730K-10.4%
Income taxes paid	$118K—	——	$247K—	$0—
Amortization Of Debt Discount Premium	$706K-36.7%	$1.12M+854%	$117K-37.4%	$187K+26.4%
Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net	——	-$38K—	$0—	$0—
Increase (Decrease) in Prepaid Expense and Other Assets	——	$3.35M—	——	——
Inventory write-downs	——	$529K+3,427%	$15K—	——
Operating lease right-of-use asset amortization	$44K-64.2%	$123K+83.6%	$67K+8.1%	$62K—
Other Noncash Income (Expense)	——	——	——	——
Payments To Acquire Businesses Gross	$0-100%	$30M—	$0—	$0—
Payments to Acquire Intangible Assets	$0—	——	$775K—	——
Common stock issuance for private placement	$0-100%	$7M—	$0—	$0—
Proceeds from issuance of common stock relating to employee stock plans	——	——	$229K+33.9%	$171K—
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction	$0-100%	$386K—	$0—	$0—
Increase Decrease In Accrued Medicaid Rebates	——	——	——	$768K—
Inventory Stepup	$5.09M—	$0—	$0—	——
Income Taxes Paid, Net	$118K—	——	$247K—	$0—
Free cash flow	——	——	$6.82M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Eton Pharmaceuticals, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Eton Pharmaceuticals, Inc. generate?: Eton Pharmaceuticals, Inc. (ETON) generated $29.5M in operating cash flow over the trailing twelve months.
What is Eton Pharmaceuticals, Inc.'s free cash flow?: After $408.0K of capital expenditures, Eton Pharmaceuticals, Inc.'s free cash flow was $29.1M over the trailing twelve months, up 1588.2% year over year.
Where does Eton Pharmaceuticals, Inc.'s cash flow data come from?: Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.